Person profile

Public information reviewed

Anthony DiGiandomenico

Board role

Director · MDB Capital Holdings, LLC (NASDAQ: MDBH)

Board role

Director · EXOZYMES INC. (NASDAQ: EXOZ)

Board role

Director · ENDRA Life Sciences Inc. (NASDAQ: NDRA)

Board role

Director · ClearSign Technologies Corp (NASDAQ: CLIR)

MDB Capital Holdings, LLC (NASDAQ: MDBH)

Director · Current mandate

Director · Executive
FollowSave PDF
More
Reports & analysisAlpha Eval
Public sources
16 reviewed
Profile ownership
Not yet claimed
Last reviewed
May 16, 2026
View sources

Profile

Identity, professional record and current appointments.

Overview

Professional record at a glance

A concise summary of information supported by the cited public sources. Missing information is treated as unknown, not as a negative finding.

Current roles
44 current organizations shown on this profile
Board positions
44 supported by public sources, 0 supplied by the profile owner
Committee roles
2Roles supported by the sources cited on this profile
Qualifications
Not establishedNo qualification is currently confirmed by the cited sources

Professional narrative

About

Co-founder of MDB Capital Group LLC focusing on corporate finance and capital formation. Extensive experience in private capital, public offerings, PIPEs, and mergers and acquisitions for growth-oriented companies.

Sources are shown with the information they support.

Current roles

Appointments & responsibilities

Board appointments

Governance

Board appointments, committee responsibilities and disclosed relationships.

Board and advisory record

Board service

Sources are shown with each role, education record, or credential.

Director

MDB Capital Holdings, LLC

2021-01-01 · current

Confirmed by public sourceView source

Director

EXOZYMES INC.

2019-01-01 · current

Confirmed by public sourceView source

Director

ENDRA Life Sciences Inc.

2013-01-01 · current

Confirmed by public sourceView source

Director

ClearSign Technologies Corp

Current · start date not disclosed

Confirmed by public sourceView source

Connections

Explore the roles, education and affiliations published in this record.

ClearSign Technologies Corp

Open ClearSign Technologies Corp profile →

Director at ClearSign Technologies Corp

Start not stated → End not stated

current · source reported

Observed: 2026-09-15

ClearSign Technolo…ClearSign Technologies CorpENDRA Life Science…ENDRA Life Sciences Inc.EXOZYMES INC.EXOZYMES INC.MDB Capital Holdin…MDB Capital Holdings, LLCAnthony DiGiandome…

Dashed lines mark past roles. Select a connection to see its dates and sources.

Relationship map

Connected through the public record

Direct relationships from verified facts and published résumé records. Private connections are excluded.

Direct public links only

Only published affiliations are shown here. Private relationships require authorized access.

Experience

Career history, education, credentials and public contributions.

Published record

Featured coverage

Selected publications and public sources used to establish this profile. Inclusion records provenance; it is not an endorsement.

Source 1 · Sec FilingCLIR DEF 14A executive officersSupports Executive company, Executive title.Open sourceSource 2 · Sec FilingNDRA 10-K executive officersSupports AI and ML experience, Cybersecurity experience, Executive company, Executive title, Other Company Role, Technology background.Open sourceSource 3 · Sec FilingMDBH 10-K executive officersSupports Executive company, Executive title.Open sourceSource 4 · Sec FilingEXOZ 10-K executive officersSupports Executive company, Executive title.Open sourceSource 5 · Sec FilingCLIR DEF 14A director slateSupports Board role, Committee assignments.Open sourceSource 6 · Sec FilingMDBH DEF 14A director slateSupports Board role, Committee assignments, Executive company, Executive title.Open sourceSource 7 · Sec FilingNDRA DEF 14A director slateSupports AI and ML experience, Board role, Committee assignments, Cybersecurity experience, Technology background.Open sourceSource 8 · Sec FilingEXOZ DEF 14A director slateSupports Board role, Committee assignments.Open source

Basis

Identifiers, sources, dates and record limitations.

Identifiers

Alpha ID
alpha:person:anthony-digiandomenico
Record version
public-0

Sources

Sources and published information

Each item links to the public source used to support it. When sources disagree, the item is clearly marked for review.

AI and ML experience · CorroboratedAI and ML experience: not identified in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Board membership · Source reportedServes on the board of ClearSign Technologies Corp1 source
Verification
Source reported
Confidence
Not stated
Last reviewed
Not stated
Board membership · Source reportedServes on the board of ENDRA Life Sciences Inc.1 source
Verification
Source reported
Confidence
Not stated
Last reviewed
Not stated
Board membership · Source reportedServes on the board of EXOZYMES INC.1 source
Verification
Source reported
Confidence
Not stated
Last reviewed
Not stated
Board membership · Source reportedServes on the board of MDB Capital Holdings, LLC1 source
Verification
Source reported
Confidence
Not stated
Last reviewed
Not stated
Board role · CorroboratedBoard role: DirectorSupported by 4 public records4 sources
Verification
Corroborated
Confidence
92%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Committee assignments · CorroboratedNo committee assignment disclosed in the cited filingSupported by 3 public records3 sources
Verification
Corroborated
Confidence
88%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Committee assignments · Source reportedCommittee assignments: Audit, Compensation1 source
Verification
Source reported
Confidence
88%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Cybersecurity experience · CorroboratedCybersecurity experience: not identified in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive company · Source reportedExecutive at ClearSign Technologies Corp1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive company · Source reportedExecutive at ENDRA Life Sciences Inc.1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive company · Source reportedExecutive at EXOZYMES INC.1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive company · CorroboratedExecutive at MDB Capital Holdings, LLCSupported by 2 public records2 sources
Verification
Corroborated
Confidence
94%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive title · CorroboratedExecutive title: DirectorSupported by 3 public records3 sources
Verification
Corroborated
Confidence
94%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive title · Source reportedExecutive title: Head of New Venture Discovery1 source
Verification
Source reported
Confidence
85%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive title · Source reportedExecutive title: Head of New Venture Discovery, and Director1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Other Company Role · Source reportedAnthony DiGiandomenico is also linked to MDB Capital Group LLC as Co-founder.1 source
Verification
Source reported
Confidence
70%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Technology background · CorroboratedTechnology background: not identified in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

View all sources16 records
  1. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

    Supports: Executive company · Executive title

  2. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

    Supports: AI and ML experience · Cybersecurity experience · Executive company · Executive title · Other Company Role · Technology background

  3. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

    Supports: Executive company · Executive title

  4. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

    Supports: Executive company · Executive title

  5. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

    Supports: Board role · Committee assignments

  6. https://www.sec.gov/Archives/edgar/data/1434524/000110465926009202/clir-20260226xdef14a.htm

    Sec Proxy · Tier not stated · Reviewed Apr 25, 2026

    Supports: Director at ClearSign Technologies Corp (NASDAQ: CLIR)

  7. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

    Supports: Board role · Committee assignments · Executive company · Executive title

  8. https://www.sec.gov/Archives/edgar/data/1934642/000149315225023188/formdef14a.htm

    Sec Proxy · Tier not stated · Reviewed Apr 25, 2026

    Supports: Director at MDB Capital Holdings, LLC (NASDAQ: MDBH)

  9. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

    Supports: AI and ML experience · Board role · Committee assignments · Cybersecurity experience · Technology background

  10. https://www.sec.gov/Archives/edgar/data/1681682/000165495425012254/endra_def14a.htm

    Sec Proxy · Tier not stated · Reviewed Apr 28, 2026

    Supports: Director at ENDRA Life Sciences Inc. (NASDAQ: NDRA)

  11. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

    Supports: Board role · Committee assignments

  12. https://www.sec.gov/Archives/edgar/data/2010788/000114036125023217/ny20050076x1_def14a.htm

    Sec Proxy · Tier not stated · Reviewed Apr 28, 2026

    Supports: Director at EXOZYMES INC. (NASDAQ: EXOZ)

  13. https://www.sec.gov/Archives/edgar/data/1934642/000149315225023188/formdef14a.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership

  14. https://www.sec.gov/Archives/edgar/data/2010788/000114036125023217/ny20050076x1_def14a.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership

  15. https://www.sec.gov/Archives/edgar/data/1681682/000165495425012254/endra_def14a.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership

  16. https://www.sec.gov/Archives/edgar/data/1434524/000110465926009202/clir-20260226xdef14a.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership